Detalles de la búsqueda
1.
Comparison of the oncolytic activity of a replication-competent and a replication-deficient herpes simplex virus 1.
Immunology
; 172(2): 279-294, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444199
2.
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis.
Gut
; 72(1): 49-53, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35428657
3.
Clinical determinants of long-term survival in metastatic uveal melanoma.
Cancer Immunol Immunother
; 71(6): 1467-1477, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34709438
4.
Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines.
Cytotherapy
; 21(11): 1166-1178, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31668486
5.
Hypertonicity primes malignant melanoma cells for apoptosis.
Apoptosis
; 23(3-4): 201-209, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29435687
6.
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.
Exp Dermatol
; 27(7): 769-778, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29704887
7.
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma.
Int J Mol Sci
; 19(8)2018 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30103488
8.
Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells.
Immunology
; 146(2): 327-38, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26194553
9.
Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.
Eur J Immunol
; 44(12): 3543-59, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25211552
10.
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.
Cancer Immunol Immunother
; 64(12): 1623-35, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26515978
11.
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg.
Blood
; 122(13): 2185-94, 2013 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23958949
12.
A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.
Cancer Immunol Immunother
; 63(10): 999-1008, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24938475
13.
Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers.
Graefes Arch Clin Exp Ophthalmol
; 252(4): 679-85, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24449136
14.
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy.
J Immunother Cancer
; 12(5)2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38724462
15.
The future of affordable cancer immunotherapy.
Front Immunol
; 14: 1248867, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37736099
16.
Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremity.
Front Med (Lausanne)
; 10: 1089013, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36744147
17.
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial.
Front Med
; 17(5): 878-888, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432641
18.
Block Excision of Iridociliary Tumors Enables Molecular Profiling and Immune Vaccination.
Ophthalmology
; 124(2): 268-270, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28195057
19.
Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
Blood
; 116(13): 2277-85, 2010 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20566893
20.
A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKß-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma.
Front Immunol
; 13: 785231, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35185883